Description

Semaglutide Overview

Semaglutide is a synthetic research peptide structurally designed to mimic glucagon-like peptide-1 (GLP-1) analogs. It is of particular interest in studies related to peptide–receptor interactions, incretin pathways, and metabolic signaling. In preclinical models, Semaglutide is commonly investigated for its pharmacokinetic properties and stability compared to native GLP-1.

Product Details

• Form: Lyophilized (freeze-dried) powder

• Strength: Supplied in sterile vials (mg content per label)

• Amino Acid Sequence: HXEGTFTSDVSSYLEGQAAK-OH.steric diacid-EFIAWLRGRG

• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉

• Molecular Weight: 4113.64 g/mol

• PubChem CID: 56843331

• CAS Number: 910463-68-2

• Storage: Store in a cool, dry place; refrigerate (2–8°C) after reconstitution

Research Highlights

• GLP-1 Receptor Interaction: Investigated for its role in modulating GLP-1 receptor activity and cellular signaling.

• Peptide Stability: Noted for its prolonged half-life and resistance to enzymatic degradation.

• Pharmacokinetic Studies: Commonly used to examine controlled-release properties and peptide delivery systems.

• Metabolic Pathway Modeling: Utilized in laboratory studies exploring glucose-related signaling in vitro and in vivo.

Usage and Safety Information

This compound is intended for laboratory research use only. It is not approved for human or veterinary consumption. Standard laboratory safety procedures should be observed when handling this peptide.

Important Notices

• Provided as a lyophilized powder in sealed, sterile vials.

• Label reflects total peptide content per vial.

• Requires reconstitution (e.g., with bacteriostatic water) prior to laboratory use.

• Additional supplies such as bacteriostatic water, sterile syringes, and alcohol prep pads are necessary.

• Vial appearance, label, seal, and cap colors may differ from product photos.